Antiplatelet Thrombolysin (Anfibatide) Phase 1 Clinical Trial in Healthy Volunteers

NCT04404790 · clinicaltrials.gov ↗

PHASE1

Phase

SUSPENDED

Status

50

Enrollment

INDUSTRY

Sponsor class

Stopped Optimization of protocol

Conditions

Antiplatelet Drug

Interventions

DRUG: Anfibatide 5 IU/60kg
DRUG: Anfibatide 5 IU/60kg +0.002 IU/kg/h
DRUG: Anfibatide 5 IU/60kg +0.004 IU/kg/h
DRUG: Anfibatide 5 IU/60kg +0.008 IU/kg/h
DRUG: Anfibatide 7 IU/60kg
DRUG: Anfibatide 7 IU/60kg +0.002 IU/kg/h
DRUG: Anfibatide 7 IU/60kg +0.004 IU/kg/h
DRUG: Anfibatide 7 IU/60kg +0.008 IU/kg/h

Sponsor

Lee's Pharmaceutical Limited